Eisai
4523.T
$38.75
Share price
2.34%
Change (1 day)
-26.27%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
EPS for Eisai (4523.T)
EPS in 2023 (TTM): $2.95
According to Eisai's latest financial reports the company's current EPS (TTM) is $3.03. In 2022 the company made an earnings per share (EPS) of $2.22 a decrease over its 2021 EPS that were of $9.86.
EPS history for Eisai from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $2.95 | 32.7% |
| 2022 | $2.22 | -77.48% |
| 2021 | $9.86 | -41.88% |
| 2020 | $16.97 | -0.94% |
| 2019 | $17.13 | 52.59% |
| 2018 | $11.23 | 124.17% |
| 2017 | $5.01 | -49.42% |
| 2016 | $9.90 | 37.08% |
| 2015 | $7.22 | -11.75% |
| 2014 | $8.19 | -3.23% |
| 2013 | $8.46 | -18.56% |
| 2012 | $10.39 | -15.51% |
| 2011 | $12.29 | -3.75% |
| 2010 | $12.77 | -1.36% |
| 2009 | $12.95 |